GlassScriptPhysician profile
Joel A Trotter
NPI 1578690343
$1,748.55
in general payments reported to CMS, 2019-2025
13 companies · $15.95 in 2025
The $15.95 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $797 · 2020: $191 · 2021: $18.53 · 2022: $166 · 2023: $330 · 2024: $230 · 2025: $15.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $506.55 | 2019-2024 | Dovato, Apretude |
| Merck Sharp & Dohme LLC | $458.20 | 2019-2024 | Dificid, Zerbaxa, Recarbrio |
| Gilead Sciences, INC. | $176.26 | 2019-2020 | |
| Janssen Biotech, INC. | $168.26 | 2019-2023 | Symtuza |
| Melinta Therapeutics, LLC | $90.50 | 2019-2020 | |
| Philips North America LLC | $77.96 | 2019 | |
| Napo Pharmaceuticals INC | $58.85 | 2019-2024 | Mytesi |
| Shionogi INC | $54.65 | 2021-2023 | Fetroja |
| Insmed, INC. | $51.91 | 2019 | |
| Allergan, INC. | $40.83 | 2019-2020 | |
| Theratechnologies INC. | $32.99 | 2019-2022 | |
| Electromed, INC. | $15.95 | 2025 | Smartvest |
| Cumberland Pharmaceuticals, INC. | $15.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Trotter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.